Squarepoint’s QIAGEN NV QGENF Stock Holding History

Squarepoint’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18,000	Closed	-$494K	–	2052
2016 Q3	$494K	Buy	+18,000	New	+$494K	0.03%	566
2016 Q1	–	Sell	-13,900	Closed	-$384K	–	1710
2015 Q4	$384K	Buy	+13,900	New	+$384K	0.04%	676

Other funds holding QGENF

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Squarepoint's QGENF Position: Q4 2016 in Review

Squarepoint sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 18,000 shares — an estimated $494K sold.

Squarepoint first reported a position in QGENF in Q4 2015 and held it in 2 quarters. The position peaked at $494K in Q3 2016. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

Squarepoint reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
Squarepoint sold 18,000 QIAGEN NV shares in Q4 2016, an estimated $494K.
Squarepoint first reported a position in QIAGEN NV in Q4 2015 and held it in 2 quarters.
Squarepoint's QIAGEN NV position peaked at $494K in Q3 2016.
189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on Squarepoint's 13F filing for Q4 2016, filed 14 Feb 2017.